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ABSTRACT
Objective: To compare the diagnostic performance of microscopy using Giemsa-
stained thick and thin blood smears to a rapid malaria dipstick test (RDT) in 
detecting P. falciparum malaria in Kenyan school children. 
Design: Randomised, controlled feeding intervention trial from 1998-2001. 
Setting: Rural Embu district, Kenya. The area is considered endemic for malaria, with 
four rainy seasons per year. Chloroquine resistance was estimated in 80% of patients. 
Children had a spleen rate of 45%. 
Subjects: A sample of 515 rural Kenyan primary school children, aged 7-11 years, who 
were enrolled in a feeding intervention trial from 1998-2001. 
Main outcome measures: Percent positive and negative P. falciparum malaria status, 
sensitivity, specificity and positive and negative predictive values of RDT. 
Results: For both years, the RDT yielded positive results of 30% in children compared 
to microscopy (17%). With microscopy as the “gold standard,” RDT yielded a sensitivity 
of 81.3% in 1998 and 79.3% in 2000. Specificity was 81.6% in 1998 and 78.3% in 2000. 
Positive predictive value was 47.3% in 1998 and 42.6% in 2000, and negative predictive 
value was 95.6% in 1998 and 94.9% in 2000. 
Conclusion: Rapid diagnostic testing is a valuable tool for diagnosis and can shorten 
the interval for starting treatment, particularly where microscopy may not be feasible 
due to resource and distance limitations. 
INTRODUCTION
Malaria is among the leading causes of childhood 
morbidity and mortality, particularly in sub-Saharan 
Africa and Southeast Asia (1). In many areas, death 
rates from malaria exceed those from HIV/AIDS 
and other infections, with P. falciparum responsible 
for the greatest number of deaths. Multiple factors 
contribute to the prevalence and severity of malaria. 
These are   lack of preventive and protective measures 
such as chemical and environmental control of 
vector populations and increasing mosquito and 
parasite resistance to insecticides and  drugs, 
respectively (2, 3).   Problems with distribution and 
underutilisation of insecticide impregnated bed 
nets limit their use even though they have been 
demonstrated to be effective in reducing malaria 
incidence (4, 5). 
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 Moreover, access to diagnostic testing and 
effective antimalarial drugs is limited. Poor access 
to health facilities is a major barrier to early malaria 
diagnosis and treatment. Moreover, microscopy may 
not be available in many rural areas where trained 
personnel and adequate laboratory facilities are 
unavailable. Despite efforts made to decrease the cost of 
effective antimalarial drugs for consumers, competing 
financial demands may make it difficult for consumers 
to purchase adequate amounts of these (6). In 2000, 
in the 42 countries with 90% of worldwide childhood 
mortality, only 29% (ranging from 3-66%) of children 
under age five years had access to antimalarial drugs 
(7). Poverty creates an inability to pay for clinic visits, 
malaria testing, and purchase of drugs (8). Home 
treatment may be inadequate, with incorrect drug doses 
and/or expired drugs. Early diagnosis and treatment 
are of utmost importance to reduce morbidity and 
mortality from malaria, particularly from P. falciparum 
malaria. Early diagnosis facilitates early initiation of 
appropriate treatment, which could prevent severe 
complications and mortality. In malarious areas of 
Africa, fevers are often assumed to be malarial, and 
overdiagnosis of malaria may lead people to purchase 
and utilise malarial medications for non-malarial 
fevers. Unnecessary treatment with ineffective drugs 
and dosages contributes to development of parasite 
resistance. 
 Microscopy of blood smears stained using either 
Giemsa or Field-stains is universally considered 
the standard for malaria diagnosis (9). Yet, errors 
in diagnostic accuracy are an inherent limitation of 
microscopy (10), as it requires properly prepared 
and stained smears, well-trained microscopists, 
appropriate laboratory equipment, adequate light 
source, and periodic duplicate readings by a second 
microscopist for quality control-resources which 
are unavailable in many malaria endemic rural 
areas. Diagnosis of malaria could be improved and 
facilitated through rapid diagnosis. Aside from rapid 
dipstick technology, various techniques have been 
explored including the Quantitative Buffy Coat (QBC) 
method. While the QBC has been shown to have high 
sensitivity and specificity, it requires a centrifuge to 
prepare either capillary or venous blood samples for 
examination (11). 
 Rapid diagnostic tests (RDT) using dipsticks have 
been developed to diagnose the main types of malaria 
and do not require use of a laboratory. These are 
available for single species or all four species of malaria. 
These RDT have been developed and tested in non-
immune  travellers, clinical cases, and communities 
in endemic areas. A RDT detecting plasmodial 
histidine-rich protein 2 (HRP-2) showed a high level 
of sensitivity and specificity in non- immune travellers 
(sensitivity of 92.5% and specificity of 98.3%) (12). 
Another study using an HRP-2 dipstick in infected 
travellers found sensitivity of 90% and specificity 
of 96% (13). High sensitivity (95.4%) and specificity 
(94.1 %) was found using RDT in children admitted 
to an outpatient hospital with fever or history of 
fever in Papua, New Guinea (14). The study reported 
here sought to compare the diagnostic performance 
of microscopy using Giemsa-stained thick and 
thin blood smears to RDT in detecting P. falciparum 
malaria in Kenyan primary school children who were 
participating in a feeding intervention study. 
MATERIALS AND METHODS
Sample and study area: A sample of 515 rural Kenyan 
primary school children, aged 7-11 years, enrolled in 
a randomised, controlled feeding intervention trial 
from 1998-2001 was utilised. These children lived in 
rural Embu district southeast of Mt. Kenya (1200-
2500m), usually with two long and two short rainy 
seasons per year. The area is endemic for P. falciparum 
malaria, and the health centre and district hospital 
estimated that chloroquine resistance was present 
in approximately 80% of patients. The reported 
prevalence of malaria by parents in the study children 
at baseline was 17%. Other baseline characteristics 
of children are summarised in Table 1. 
Table 1
Baseline characteristics of children
Age   7.4±1.2
Male (%) 52
Infection* (%), examined in 523 17.8
Enlarged spleen (%), examined in 398 45.4
Faecal parasites, examined in 510 children
  Entamoeba histolytica (%)  17.6
  Giardia lamblia (%) 16
  Hookworm (%)  0.9
  Ascaris lumbricoides (%)  4.7
  Escherichia coli (%)  12.4
*C-reactive protein> 10 mg/L 
Design: The 515 children enrolled in the feeding 
intervention were tested for malaria using both 
microscopy and RDT at baseline, one year, and two 
years after the feeding intervention began. Ongoing 
morbidity data was collected at one to two month 
intervals by interviewing mothers using a questionnaire 
and by physical inspection of the child conducted by 
enumerators trained by nurses and doctors to identify 
signs and symptoms of illness including fever, chills, 
malaria and other morbidity. 
Methods for malaria detection: Three methods 
detailed below were used to assess malaria status: i) 
microscopy; ii) RDT strips, a rapid blood test; and iii) 
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a monthly morbidity determination based on reported 
and observed signs and symptoms such as fever, 
chills, and caretaker’s clinical diagnosis of malaria. 
Blood samples were obtained by venipuncture or 
finger stick annually between 1998 and 2000.
 Microscopy was performed on thick and thin 
blood smears, stained with Giemsa and allowed 
to dry. Stained slides were read independently 
by two very experienced senior technicians from 
the University of Nairobi, Department of Medical 
Microbiology in 1998 and 1999 for quality control 
purposes. In 2000, one microscopist was used, with 
periodic quality control checks by a second technician. 
Malaria parasites (mps) per 100 red blood cells were 
counted in the thin smear, and mps per 200 white 
blood cells were counted in the thick smear. The 
technicians’ independent readings demonstrated 
a high percentage of agreement (kappa=0.9039). 
Microscopy data from 1999 was excluded because 
the slides were damaged.
 Rapid testing for malaria via dipstick antigen 
capture was performed using the Vision Biotech 
Pf malaria test (Cape Town, South Africa), a rapid 
qualitative method that detects P. falciparum in either 
anti-coagulated venous blood, capillary blood, or 
serum using an immunochromatographic strip. The 
Vision Biotech test is an antigen-capture assay which 
detects the presence of specific soluble histidine-
rich protein 2 (HRP-2) present in and released from 
infected and lysed RBCs. A capture monoclonal 
antibody is immobilised on the test strip, which binds 
to the histidine rich protein. The reagent, coated with 
specific antibodies, binds to the antigen-antibody 
complex producing a red line on the strip. A control 
(C) strip and the test strip (T) are assessed to determine 
the presence or absence of P.falciparum malaria. Blood 
or serum was drawn up in a capillary tube (either 
5µL or 10µL may be used) and was then transferred 
to the test strip by gently touching the nozzle to the 
well (Figure 1a). Four drops of reaction buffer were 
then placed into the well (Figure 1b). After exactly 15 
minutes the results were obtained by comparing the 
C line to the T line (Figure 1c). Two lines signified the 
presence of P. falciparum antigens. A control line alone 
indicated that the test was performed correctly but 
no antigens were present. No visible lines indicated 
an invalid test result. 
Figure 1
Rapid diagnostic malarial test for P. falciparum 
a) Blood is transferred to the well
b)  Four drops of reaction buffer are added to the 
well 
c) Results of the rapid test are indicated on the test 
strip 
Morbidity data was obtained by home visits 
conducted every two months using a questionnaire 
administered to the child’s caretaker inquiring about 
signs and symptoms of illness on the day of the visit 
and the preceding six days. The questionnaire initially 
consisted of open-ended questions asking caretakers 
to describe any illness, followed by a structured 
questionnaire with probing questions about signs 
and symptoms which comprised a diagnosis or illness 
categories (15). Fever, chills, and the use of the term 
malaria were specifically asked about. If the child 
was at home because of illness, oral temperature 
was taken and observations of the sick child were 
recorded following a strict protocol. Morbidity results 
only from July 2000 home visit are reported in this 
paper as this was the only year with blood testing and 
microscopy data to correspond with morbidity data. 
The July home visit was the visit which most closely 
corresponded to the date of the annual malaria blood 
test. Morbidity data was not available for 1998.
Statistical analyses: Sensitivity and specificity were 
calculated using results from RDT and microscopy. 
Sensitivity and specificity were calculated using data 
from 1998 and 2000. In calculations of sensitivity 
and specificity, data were excluded for children who 
lacked both microscopic results and for children who 
lacked a RDT strip result. If children had at least one 
microscopic result and a RDT result for the same 
blood sample, their data was included for analysis. 
Sensitivity for RDT was calculated as children 
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positive by both methods divided by (positives by 
both methods + positives by RDT alone); specificity 
as children negative by both methods divided by 
(negatives by both methods + positives by RDT alone). 
Positive predictive value was calculated as positives 
by both methods divided by the total number who 
tested positive, and negative predictive value was 
calculated as children negative by both methods 
divided by the total number who tested negative.
Approval by the UCLA Human Subject Protection 
Committee, the Ethics Committee of the University 
of Nairobi School of Medicine, and the Office of 
the President were obtained prior to commencing 
the study. Verbal informed consent by parents and 
assent by children and community permission were 
also obtained. 
RESULTS 
Overall, the three types of diagnostic methods 
produced widely differing results. Rapid diagnostic 
tests yielded the highest rates of positives, detecting 
nearly double the number of children with P. 
falciparum as microscopy and two to three times 
greater the number diagnosed with “clinical malaria” 
by morbidity reports (Table 2). Using RDT results of 
those who were tested each year, 6% of the sample 
tested positive both years and 39% tested negative. 
Morbidity reports for 2000 indicated that 458 (7.0%) 
children experienced fever and chills and were 
identified as having malaria by the caretaker. 
Table 2
Descriptive results for RDT, microscopy, and reported 
morbidity data
           Positive
Year        1998     2000 
 No.  (%) No.  (%)
RDT 515 31.7 346 31.2 
Microscopy 456 16.9 360 17.8
Reported and 
observed morbidity* -  458 7.0
* Fever, chills, and presumptive diagnosis of malaria 
by caretaker 
-  Morbidity data temporally corresponding to blood 
tests not available for 1998 
Using microscopy as the “gold standard,” the RDT 
yielded a sensitivity of 81.3% in 1998 and a sensitivity 
of 79.3% in 2000 and specificity of 81.6% in 1998 
and 78.3% in 2000 (Table 3). Using data from 1998, 
a positive predictive value of 47.3% was obtained, 
while in 2000 the positive predictive value was 42.6%. 
The calculated negative predictive value was 95.6% 
in 1998 and 94.9% in 2000. Data from 445 children 
were included in analysis for 1998 and 344 children in 
2000. Utilising microscopy as the “gold standard”, the 
RDT has a low rate of false negatives (about 3%) but 
a higher rate of false positives (15-28%) (Table 4). 
Table 3






Positive predictive value 47.3 42.6
Negative predictive value 95.6 94.9
Table 4
Percent agreement, false negatives, and false positives 
(RDT compared to microscopy) by year
 1998 2000
Agreement 81.6 78.5
False negatives  3.1 3.5
False positives 15.3 18.0
DISCUSSION
The use of a RDT for P. falciparum malaria detection in 
a group of children living in an endemic area yielded 
nearly double the positive results than microscopy 
using Giemsa-stained blood smears. Previous studies 
of asymptomatic individuals comparing microscopy 
to RDT that screen for HRP-2 in endemic areas yielded 
average sensitivity of 88% (range 86-90%) (10). The 
sensitivity values obtained in our study are somewhat 
lower than these results, sensitivity of (81.33% in 
1998 and 79.3% in 2000). In terms of specificity, our 
obtained specificity values (81.6% in 1998 and 78.3% in 
2000) are lower than in field studies of asymptomatic 
individuals in endemic areas (99.90%, range 99.7 
100%) (10). However, one study of a RDT detecting 
HRP-2 antigen among Kenyans in an endemic area 
yielded a specificity of 88% (84-92%, n=285), close 
to that obtained in the present study (16). In the 
epidemiologic sense, assessing specificity of RDT in 
endemic areas is difficult. There is no definitive way 
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of knowing that a negative microscopy test result 
coincides with absence of malaria infection since 
commonly used microscopy does not perform as a 
true “gold standard” (16).
 The lower specificity obtained in our study 
may also be due in part to the population sampled 
in our study, which included both symptomatic 
and asymptomatic children. Some children who 
had experienced fever and chills were reported by 
caretakers as having clinical malaria. Likewise, the 
low positive predictive value of RDT found in this 
population could be related to the fact that tests 
were performed in asymptomatic and symptomatic 
children. Prevalence of a condition in the population 
tested influences the positive predictive value. So, had 
tests been carried only in symptomatic children, the 
positive predictive value obtained would have been 
higher. The RDT yielded a high negative predictive 
value (95.6% in 1998 and 94.9% in 2000). Hence, if 
children tested negative for malaria by the RDT, 
they were likely to also be negative for malaria by 
microscopy.
 Nearly double the number of positive findings 
for malaria was detected by RDT than by microscopy, 
in 31% of children versus 17%, respectively. Concern 
has been expressed about false positives using HRP-
2 dipstick tests due to persistent HRP-2 antigen in 
circulation for up to two weeks after viable parasites 
are eliminated from blood. Presence of gametocytes 
has also been suggested as a cause of false positive 
results, but Beadle et al (16)  analysis of gametocytaemia 
among subjects with false-positive dipsticks found no 
indication that gametocyte presence was responsible 
for false positive results.
 Clinical diagnosis of malaria is problematic as 
many of the signs and symptoms are very nonspecific. 
Morbidity reports are a poor method to detect malaria. 
The figures obtained were much lower than the results 
obtained for RDT and microscopy. Mild cases of 
malaria are likely under-diagnosed by caretakers. On 
the other hand, clinical malaria is often overdiagnosed 
as any febrile event tends to be identified as malaria 
by the mother or caretaker. Also the timing of the 
blood testing for malaria and the morbidity home 
visits were not temporally coordinated (blood test 
once a year and home visits every two months). 
Although we picked the home visit for morbidity 
as close to the blood test as possible, these often did 
not coincide exactly. The reported symptoms are 
problematic because the July home visit did not take 
place on the same day, so reported symptoms do not 
exactly coincide with the blood testing as laboratory 
tests took place throughout the months of July and 
August. Additionally, the July home visit did not 
coincide with the season of rainfall. The heaviest rains 
occur in April and November, so in July there were 
still some residual swamps from the spring rains. 
 A RDT allows for rapid diagnosis of malaria as 
it only requires 15-20 minutes to obtain results and 
can be carried out by a trained community health 
worker (CHW) close to a person’s home without 
travel by foot, often 3-5 km, to a health centre. No 
laboratory, electricity, or microscope is required. Rapid 
diagnostic testing has the potential to provide much 
earlier diagnosis than microscopy at a health facility 
and could allow the CHW to initiate appropriate 
treatment immediately after diagnosis is made. In 
contrast, a visit to a health centre may not be feasible 
given the distance and the prohibitive cost of the 
visit, the microscopic examination of blood, and any 
recommended medications may result in delays in 
seeking medical care or not seeking medical care 
altogether.
 Use of RDT by trained volunteer barangay 
(village) health workers in the rural Philippines was 
well accepted and accurately performed, resulting 
in higher sensitivity than symptoms or microscopic 
examination of slides prepared by local health workers 
(17). In addition, patients expressed a preference for 
the RDT, and increases were seen in compliance and 
treatment-seeking behaviour (17). Rapid diagnostic 
exams have also been effective, allowing for immediate 
administration of treatment in peripheral areas where 
access to microscopy diagnosis and health centres is 
difficult in Brazil and Thailand (18, 19).
 While use of a RDT would not address the 
expense of malarial medications, it represents a 
feasible and relatively inexpensive diagnostic tool 
for malaria with potential to reduce mortality and 
morbidity from malaria through early diagnosis 
and treatment. The cost of RDT test strips detecting 
only  P. falciparum is under US$1.00, while test 
strips detecting multiple strains cost somewhat 
more than US$1.00. This cost is relatively low 
compared to the cost of maintaining a laboratory 
technician, a microscope, a light source, slides, and 
stains. Rapid diagnostic tests are now available 
from many biotechnology companies in the United 
States, Europe, Africa, and India. In addition, RDT 
technology has potential to reduce inadequate home 
treatment with inadequate doses and inappropriate 
antimalarial drugs in the market by accurately 
diagnosing malaria.
 Despite these advantages, RDT does not allow 
examination of parasite loads; these would have to be 
assessed via microscopy. The RDT used in this study 
only tests for P. falciparum; however, multivalent RDT 
are now available and under further development 
to allow for diagnosis of all four species of malaria 
parasites. Maintaining a steady supply of RDT may be 
problematic given logistic and distribution limitations 
in certain areas. Adequate distribution and storage 
networks and facilities are necessary to ensure that 
tests provided are not damaged by heat and humidity 
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(20). Health policy, administrative capacities, and 
knowledge of the status of malaria drug resistance 
are needed to address problems with access to 
effective malarial medication following diagnosis 
and distribution of medications. Rapid diagnostic 
tests should be integrated with the evaluation of other 
febrile illnesses, particularly in high risk groups such 
as young children and pregnant women (20). Further 
studies are badly needed comparing the actual time to 
diagnosis and treatment of malaria and relative cost 
and health outcomes with the use of RDT by CHWs 
with prompt diagnosis and appropriate treatment. 
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